Drug delivery via patches and oral dissolvable films is the core competency of Labtec. Since 20 years Labtec is involved in this field.
Today transdermal and topical patches are well established dosage forms, with highest acceptance by patients and caregivers. Oral dissolvable films on the other hand are relatively new in the pharmaceutical world and Labtec is on the forefront of this exciting development which will increase patient compliance in the near future.
A transdermal patch or transdermal system (TDS) is a medicated adhesive patch that is placed on the skin to deliver a specific dose of drug through the skin and into the bloodstream.>>
Topical patches deliver drugs to a local site of action. This convenient and safe way of administering a drug offers considerable advantages over gels, ointments and creams, and is generally extremely well received by patients.>>
Labtec's technology makes it possible for buccal patches to deliver drugs through the lining of the mouth (the buccal mucosa) and through the gums (the gingiva).>>
Labtec's Rapidfilm®, a proprietary oral film technology, is an innovative oral dosage form that combines the application ease of a liquid with the stability and dosing accuracy of a tablet.>>
APR Applied Pharma Research s.a., Labtec GmbH and Norgine BV Announce the Signature of an Exclusive Licensing Agreement under Which Norgine Will Market and Distribute Setofilm™ >>
APR Applied Pharma Research and Labtec announce that the Ondansetron Oral Dispersible Film is now available for licensing in Europe and selected non European countries, after having received marketing authorization. >>